In March, ResApp announced to have completed the initial integration of ResAppDx-EU into Coviu’s telehealth platform and that ResApp and Coviu had agreed upon a per test fee (range of $ 5-10 per test) for the use of ResAppDx-EU. Meanwhile, ResApp also executed Joint Development Agreement with Phenix Health for integration of ResAppDx-EU into Phenix’s Australian telehealth...
Wheezo asthma diagnostic and monitoring technology Respiri has developed its wheezo device and eHealth software as a service technology to support the management of respiratory health. Machine learning is employed to detect wheeze via the wheezo device and app. Wheeze is a typical asthma symptom and is common in other respiratory disorders. The technology is...
Medicare billing app vendor Synapse Medical Services has partnered with virtual GP clinic Phenix Health to provide a mobile telehealth and billing solution for the COVID-19 pandemic. Doctors can complete a telehealth consult on the Phenix platform, bill it, and receive a response from Medicare instantly to their phone along with overnight payment. For the...
* RESPIRI LTD – ANNOUNCES SIGNING OF A JOINT DEVELOPMENT AGREEMENT (JDA) WITH PHENIX HEALTH PTY LTD * RESPIRI-UNDER DEAL,WHEEZO EHEALTH SAAS MONITORING PLATFORM INTEGRATED INTO PHENIX PROPRIETARY TELEHEALTH PLATFORM, PATIENT DASHBOARDS & ASTHMA PLANS https://au.investing.com/news/stock-market-news/briefrespiri-announces-signing-of-a-joint-development-agreement-with-phenix-health-2092571
Respiri’s wheezo respiratory health monitoring technology will be integrated within Phenix Health’s telehealth platform. The parties have inked a joint development agreement which will involve integrating Respiri’s wheezo eHealth software as a service asthma diagnostic and monitoring technology with Phenix’s telehealth platform. You can view the full article here: https://smallcaps.com.au/respiri-expands-wheezo-telehealth-market-phenix-partnership/
ASX-listed ResApp Health will partner with Brisbase-headquartered telehealth provider Phenix Health to integrate ResApp’s acute respiratory diagnostic test into Phenix’s telehealth app. ResApp has recently completed a similar integration of ResAppDx-EU into Coviu’s telehealth platform and is expecting to have it available for use in a few months. The company is also about to launch a consumer-focused...
Joint telehealth development to assist in diagnosing respiratory disease. For full news article please visit: https://www.businessnewsaus.com.au/articles/joint-telehealth-development-to-assist-in-diagnosing-respiratory-disease.html
Press Release Brisbane, Australia, 24 March 2020 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, and Phenix Health Pty Ltd, mobile clinic software developers and providers of an online virtual clinic, have entered into a joint development agreement (JDA) to integrate ResApp’s acute...
Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI cultivate one-to-one customer service.
Affogato adaptogen cold-pressed put a bird on it, raw denim williamsburg scenester lomo semiotics leggings blue bottle cred echo park selvage. Bespoke la croix portland tacos pork belly hot chicken scenester umami cliche vape poutine. PBR&B pickled wayfarers tilde. Palo santo thundercats fingerstache man braid lomo.
OUR AFFILIATES
Phenix Health delivers online health services 24/7 provided by Australian doctors and healthcare professionals.